En esta página
01ANTX precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
ANTX AN2 Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$5,71
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,00mínimo 52 semanas
$7,19máximo 52 semanas
Capitalización Bursátil (MRQ)
$207M
P/E
-4.9
BPA
$-1.16
tus insignias
Rango 52S
$1–$7
Calificación del Analista
STRONG BUY
Precio Objetivo
$9
P/E
-4.9
ROE
-57.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ANTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$5.71
Capitalización Bursátil (MRQ)
$207M
P/E
-4.9
BPA
$-1.16
ROE
-57.7%
Rango 52S
$1–$7
ANTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-1.162021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ANTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.9promedio 5A ≈-3.2 | ≈-3.2 | · | · | |
| P/C (MRQ) | 2.7promedio 5A ≈1.0 | ≈1.0 | 1.9 | Sobrevalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | -5.2promedio 5A ≈-2.5 | ≈-2.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 3.0promedio 5A ≈2.0 | ≈2.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ANTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -45.7%promedio 5A ≈-46.3% | ≈-46.3% | -1.5% | Débil | |
| ROE | -57.7%promedio 5A ≈-53.0% | ≈-53.0% | -16.7% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ANTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 14.3 | · | 4.7 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 2.3 | · | 2.9 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.1%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.18 | $-0.28 | 34.6% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.29 | $-0.23 | -23.6% |
| 31 de diciembre de 2025 | $-0.29 | $-0.24 | -18.5% | |
| 30 de septiembre de 2025 | $-0.31 | $-0.22 | -38.1% | |
| 30 de junio de 2025 | $-0.21 | $-0.34 | 38.2% | |
| 31 de marzo de 2025 | $-0.35 | $-0.26 | -32.1% | |
| 31 de diciembre de 2024 | $-0.25 | $-0.26 | 3.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $25M | $40M | $55M | $29M | $16M | |
| SG&A Expense | $13M | $14M | $15M | $13M | $5M | |
| Operating Expenses | $38M | $57M | $70M | $42M | $22M | |
| Operating Income | $-38M | $-57M | $-70M | $-42M | $-22M | |
| Interest Income | $3M | $5M | $5M | · | · | |
| Other Non-op | $1.0K | $1.0K | $43.0K | $1M | $-38.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-35M | $-51M | $-65M | $-41M | $-22M | |
| EPS (Basic) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| EPS (Diluted) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| Shares (Basic) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| Shares (Diluted) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| EBITDA | $-38M | $-57M | · | $-42M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $21M | $16M | $27M | $12M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | |
| Current Assets | $60M | $86M | $111M | $99M | $60M | |
| Other Non-current Assets | $0 | $804.0K | $1M | $720.0K | · | |
| Total Assets | $62M | $92M | $139M | $103M | $65M | |
| Accounts Payable | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $2M | $4M | $7M | $3M | $1M | |
| Current Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Other Non-current Liabilities | $170.0K | $0 | · | · | · | |
| Total Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Paid-in Capital | $294M | $288M | $279M | $185M | · | |
| Retained Earnings | $-241M | $-206M | $-154M | $-90M | $-47M | |
| AOCI | $57.0K | $31.0K | $275.0K | $-374.0K | $-27.0K | |
| Stockholders' Equity | $53M | $82M | $125M | $95M | $-47M | |
| Liabilities + Equity | $62M | $92M | $139M | $103M | $65M | |
| Shares Outstanding | 27,413,171 | 29,919,634 | 29,741,445 | 19,402,658 | 2,730,298 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $8M | $8M | $4M | $974.0K | |
| Restructuring | · | $2M | · | · | · | |
| Operating Cash Flow | $-30M | $-49M | $-53M | $-33M | $-20M | |
| Investing Cash Flow | $28M | $55M | $-43M | $-22M | $-50M | |
| Stock Issued | $86.0K | $147.0K | $366.0K | · | · | |
| Net Stock Activity | $86.0K | $147.0K | · | · | · | |
| Financing Cash Flow | $113.0K | $372.0K | $85M | $70M | $79M | |
| Net Change in Cash | $-1M | $6M | $-12M | $15M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -45.7% | -44.5% | · | -48.8% | · | |
| ROE | -57.7% | -60.6% | · | -40.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | · | · | 13.7 | · | |
| Quick Ratio | 2.3 | · | · | 3.8 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.94 | $2.74 | · | $4.92 | · | |
| Cash Flow / Share | $-0.99 | $-1.65 | · | $-2.18 | · | |
| Cash / Share | $0.73 | $0.71 | · | $1.40 | · | |
| EPS (TTM) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-51M | $-65M | $-41M | · | |
| Market Cap | $31M | $41M | · | $185M | · | |
| P/E | -1.0 | -0.8 | -7.5 | -3.4 | · | |
| P/B | 0.6 | 0.5 | · | 1.9 | · | |
| P / Tangible Book | 0.6 | 0.5 | 4.9 | 1.9 | · | |
| P / Cash Flow | -1.0 | -0.8 | · | -5.5 | · | |
| Earnings Yield | -101.8% | -124.6% | -13.4% | -29.3% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $7M | $7M | $7M | $3M | $8M | $5M | $8M | $12M | $15M | $15M | $14M | $14M | $12M | $9M | $7M | |
| SG&A Expense | $3M | $4M | $2M | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | |
| Operating Expenses | $9M | $11M | $9M | $10M | $7M | $12M | $9M | $14M | $16M | $18M | $19M | $18M | $17M | $16M | $12M | $12M | |
| Operating Income | $-9M | $-11M | $-9M | $-10M | $-7M | $-12M | $-9M | $-14M | $-16M | $-18M | $-19M | $-18M | $-17M | $-16M | $-12M | $-12M | |
| Interest Income | $720.0K | $523.0K | $605.0K | $687.0K | $754.0K | $888.0K | $1M | $1M | $1M | $2M | · | · | · | · | · | · | |
| Other Non-op | $-1.0K | · | · | · | · | · | $-1M | $1M | $0 | $1.0K | $-3M | $1M | $797.0K | $716.0K | $634.0K | $431.0K | |
| Net Income | $-8M | $-10M | $-9M | $-9M | $-6M | $-11M | $-8M | $-13M | $-14M | $-17M | $-17M | $-17M | $-16M | $-15M | $-12M | $-11M | |
| EPS (Basic) | $-0.18 | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | |
| EPS (Diluted) | $-0.18 | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | |
| Shares (Basic) | 44,760,766 | 34,059,876 | · | 30,276,230 | 30,172,328 | 30,053,659 | · | 29,841,169 | 29,824,725 | 29,763,278 | · | 25,645,421 | 19,497,494 | 19,385,646 | · | 19,347,148 | |
| Shares (Diluted) | 44,760,766 | 34,059,876 | · | 30,276,230 | 30,172,328 | 30,053,659 | · | 29,841,169 | 29,824,725 | 29,763,278 | · | 25,645,421 | 19,497,494 | 19,385,646 | · | 19,347,148 | |
| EBITDA | $-9M | $-11M | · | $-10M | $-7M | $-12M | · | $-14M | $-16M | $-18M | · | $-18M | $-17M | $-16M | · | $-12M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $53M | $20M | $18M | $18M | $20M | $21M | $34M | $27M | $25M | $16M | $33M | $41M | $27M | $27M | $29M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $5M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | |
| Current Assets | $80M | $87M | $60M | $64M | $68M | $70M | $86M | $98M | $107M | $116M | $111M | $126M | $98M | $90M | $99M | $107M | |
| Other Non-current Assets | $216.0K | · | $0 | $0 | $0 | $304.0K | $804.0K | · | $1M | $1M | $1M | $1M | $720.0K | $720.0K | $720.0K | $720.0K | |
| Total Assets | $82M | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $5M | $3M | $4M | $2M | $1M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $6M | $4M | $3M | $2M | |
| Current Liabilities | $6M | $6M | $9M | · | · | · | $10M | $10M | · | · | · | $15M | $11M | $9M | $7M | $4M | |
| Other Non-current Liabilities | $170.0K | $170.0K | $170.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $6M | $9M | $7M | $7M | $8M | $10M | $10M | $10M | $11M | $14M | $15M | $11M | $9M | $7M | $4M | |
| Paid-in Capital | $335M | $333M | $294M | $293M | $292M | $290M | $288M | $286M | $284M | $282M | $279M | $277M | $209M | $188M | $185M | $184M | |
| Retained Earnings | $-259M | $-251M | $-241M | $-232M | $-223M | $-216M | $-206M | $-198M | $-186M | $-171M | $-154M | $-138M | $-121M | $-105M | $-90M | $-78M | |
| AOCI | $-23.0K | $-5.0K | $57.0K | $64.0K | $25.0K | $48.0K | $31.0K | $112.0K | $-27.0K | $53.0K | $275.0K | $-122.0K | $-119.0K | $-175.0K | $-374.0K | $-541.0K | |
| Stockholders' Equity | $76M | $82M | $53M | $60M | $69M | $73M | $82M | $88M | $98M | $111M | $125M | $139M | $88M | $83M | $95M | $106M | |
| Liabilities + Equity | $82M | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | |
| Shares Outstanding | 36,308,669 | 35,985,599 | 27,413,171 | 27,371,154 | 27,376,461 | 30,141,517 | 29,919,634 | 29,868,583 | 29,829,040 | 29,815,663 | 29,741,445 | 29,741,445 | 21,928,452 | 19,426,452 | 19,402,658 | 19,402,658 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $972.0K | $1M | $1M | $801.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | $-9.0K | $2M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-12M | $-5M | $-6M | $-8M | $-11M | $-5M | $-12M | $-14M | $-18M | $-17M | $-12M | $-13M | $-12M | $-8M | $-9M | |
| Investing Cash Flow | $-4M | $8M | $7M | $6M | $6M | $9M | $-7M | $19M | $16M | $26M | $420.0K | $-62M | $8M | $11M | $6M | $-2M | |
| Stock Issued | · | · | $0 | $48.0K | $0 | $38.0K | $0 | $23.0K | $0 | $124.0K | $0 | $167.0K | $0 | $199.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | $38.0K | · | · | · | $124.0K | · | · | · | $199.0K | · | · | |
| Financing Cash Flow | $1M | $37M | $0 | $48.0K | $0 | $65.0K | $0 | $23.0K | $0 | $349.0K | $-321.0K | $66M | $19M | $199.0K | $0 | $-10.0K | |
| Net Change in Cash | $-9M | $34M | $2M | $-217.0K | $-2M | $-1M | $-12M | $7M | $2M | $9M | $-17M | $-8M | $14M | $-510.0K | $-2M | $-12M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.4% | -11.9% | · | -11.3% | -7.0% | -10.5% | · | -10.1% | -13.9% | -15.7% | · | -12.7% | -14.4% | -14.5% | · | -20.6% | |
| ROE | -11.3% | -12.9% | · | -12.6% | -7.7% | -11.6% | · | -11.2% | -15.5% | -17.2% | · | -13.7% | -15.5% | -15.5% | · | -21.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 15.7 | · | · | · | · | · | 9.8 | · | · | · | 8.5 | 8.8 | 10.5 | · | 24.2 | |
| Quick Ratio | 7.9 | 9.6 | · | · | · | · | · | 3.3 | · | · | · | 2.2 | 3.7 | 3.1 | · | 6.5 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.09 | $2.27 | · | $2.21 | $2.51 | $2.43 | · | $2.94 | $3.30 | $3.71 | · | $4.67 | $4.00 | $4.25 | · | $5.44 | |
| Cash Flow / Share | · | $-0.35 | · | · | · | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.60 | · | · | |
| Cash / Share | $1.22 | $1.49 | · | $0.66 | $0.67 | $0.66 | · | $1.12 | $0.90 | $0.83 | · | $1.10 | $1.86 | $1.37 | · | $1.48 | |
| EPS (TTM) | $-1.07 | $-1.10 | · | $-1.12 | $-1.24 | $-1.51 | · | $-1.96 | $-2.18 | $-2.51 | · | $-0.94 | $-0.88 | $-0.60 | · | $-7.68 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-36M | $-35M | · | $-34M | $-37M | $-45M | · | $-61M | $-65M | $-66M | · | $-60M | $-54M | $-49M | · | $-37M | |
| Market Cap | $176M | $123M | · | $35M | $29M | $41M | · | $32M | $64M | $97M | · | $478M | $186M | $192M | · | $337M | |
| P/E | -4.5 | -3.1 | · | -1.1 | -0.9 | -0.9 | · | -0.5 | -1.0 | -1.3 | · | -17.1 | -9.7 | -16.4 | · | -2.3 | |
| P/B | 2.3 | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | |
| P / Tangible Book | 2.3 | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | |
| P / Cash Flow | · | -10.2 | · | · | · | -3.9 | · | · | · | -5.5 | · | · | · | -16.5 | · | · | |
| Earnings Yield | -22.1% | -32.2% | · | -88.2% | -117.0% | -111.0% | · | -183.2% | -101.4% | -77.2% | · | -5.9% | -10.3% | -6.1% | · | -44.2% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-35M | $-51M | $-65M | $-41M | $-22M |
| EPS Diluido | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 6.9 | · | · | 13.7 | · |
| Ratio Rápido | 2.3 | · | · | 3.8 | · |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 69 declarantes · $120.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
69
Valor en tenencia
$120.4M
Nuevas posiciones
29
Posiciones cerradas
14
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 29 (+5 vs trimestre anterior) | 14 (+6 vs trimestre anterior) | 15 (+2 vs trimestre anterior) | 13 (+5 vs trimestre anterior) | +3.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Vivo Capital, LLC | $15 263 618 | 3 153 640 | 12,68% | Acciones |
| Commodore Capital LP | $14 199 011 | 2 933 680 | 11,79% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $11 222 469 | 2 318 692 | 9,32% | Acciones |
| BlackRock, Inc. | $8 060 991 | 1 665 494 | 6,69% | Acciones |
| Spruce Street Capital LP | $8 039 593 | 1 661 073 | 6,68% | Acciones |
| Almitas Capital LLC | $7 110 584 | 1 469 129 | 5,90% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 995 332 | 1 238 705 | 4,98% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4 840 000 | 1 000 000 | 4,02% | Acciones |
| CITADEL ADVISORS LLC | $4 607 665 | 951 997 | 3,83% | Acciones |
| Boxer Capital Management, LLC | $3 625 329 | 749 035 | 3,01% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 378 664 | 697 806 | 2,81% | Acciones |
| SummitTX Capital, L.P. | $2 891 673 | 597 453 | 2,40% | Acciones |
| Balyasny Asset Management L.P. | $2 691 171 | 556 027 | 2,23% | Acciones |
| Stonepine Capital Management, LLC | $2 670 190 | 551 692 | 2,22% | Acciones |
| AMERIPRISE FINANCIAL INC | $2 599 390 | 537 064 | 2,16% | Acciones |
| Sio Capital Management, LLC | $2 564 876 | 529 933 | 2,13% | Acciones |
| Ally Bridge Group (NY) LLC | $2 547 365 | 526 315 | 2,12% | Acciones |
| Prosight Management, LP | $2 297 248 | 474 638 | 1,91% | Acciones |
| Woodline Partners LP | $2 225 456 | 459 805 | 1,85% | Acciones |
| STATE STREET CORP | $1 508 154 | 311 602 | 1,25% | Acciones |
| VANGUARD GROUP INC | $1 231 280 | 1 080 070 | 1,02% | Acciones |
| NORTHERN TRUST CORP | $1 040 217 | 214 921 | 0,86% | Acciones |
| Seven Fleet Capital Management LP | $1 011 299 | 208 946 | 0,84% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $953 093 | 196 920 | 0,79% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $869 235 | 179 594 | 0,72% | Acciones |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $810 438 | 167 446 | 0,67% | Acciones |
| BANK OF AMERICA CORP /DE/ | $705 686 | 145 803 | 0,59% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $627 748 | 129 700 | 0,52% | Acciones |
| GOLDMAN SACHS GROUP INC | $425 596 | 87 933 | 0,35% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $368 058 | 76 045 | 0,31% | Acciones |
| UBS Group AG | $358 576 | 74 086 | 0,30% | Acciones |
| Walleye Capital LLC | $349 153 | 72 139 | 0,29% | Acciones |
| Bank of New York Mellon Corp | $327 552 | 67 676 | 0,27% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $310 825 | 64 220 | 0,26% | Acciones |
| TWO SIGMA ADVISERS, LP | $301 986 | 264 900 | 0,25% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $289 916 | 59 900 | 0,24% | Acciones |
| ADAR1 Capital Management, LLC | $284 631 | 58 808 | 0,24% | Acciones |
| MORGAN STANLEY | $238 995 | 49 379 | 0,20% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $194 399 | 40 165 | 0,16% | Acciones |
| Velan Capital Investment Management LP | $193 600 | 40 000 | 0,16% | Acciones |
| Nuveen, LLC | $171 012 | 35 333 | 0,14% | Acciones |
| DEUTSCHE BANK AG\ | $125 056 | 25 838 | 0,10% | Acciones |
| RHUMBLINE ADVISERS | $117 810 | 24 342 | 0,10% | Acciones |
| WELLS FARGO & COMPANY/MN | $108 363 | 22 389 | 0,09% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $77 019 | 15 913 | 0,06% | Acciones |
| Invesco Ltd. | $66 981 | 13 839 | 0,06% | Acciones |
| LPL Financial LLC | $59 774 | 12 350 | 0,05% | Acciones |
| CITIGROUP INC | $59 373 | 12 267 | 0,05% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $58 980 | 12 186 | 0,05% | Acciones |
| JPMORGAN CHASE & CO | $55 184 | 10 971 | 0,05% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BML Investment Partners, L.P. ×3 presentaciones | 18 de junio de 2025 | 1,40% | Enmienda | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 19 insiders · 9 directivos · 5 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Eric Easom | Chief Executive Officer | 19 de marzo de 2026 D | 368 630 | 0 | 0 | $0 |
| Lucy Day | Chief Financial Officer | 19 de marzo de 2026 D | 118 363 | 0 | 2 | $-8 862 |
| Cameron C. Trenor III | Chief Medical Officer | 15 de septiembre de 2026 A | 116 667 | 0 | 0 | $0 |
| Sarah Joanne Williams | Principal Accounting Officer | 1 de septiembre de 2026 S | 66 311 | 0 | 3 | $-3 025 |
| Sanjay Chanda | Chief Development Officer | 19 de marzo de 2026 D | 118 823 | 0 | 2 | $-9 311 |
| Stephen David Prior | Chief Strategy Officer | 6 de enero de 2026 S | 59 086 | 0 | 3 | $-7 363 |
| Kevin Michael Krause | Chief Strategy Officer | 15 de marzo de 2024 A | 31 914 | 0 | 0 | $0 |
| Paul Eckburg | Chief Medical Officer | 15 de marzo de 2024 A | 51 416 | 0 | 0 | $0 |
| Michael Adrian Nazak | Chief Accounting Officer | 15 de febrero de 2023 A | · | 0 | 0 | $0 |
| Robin Shane Readnour | Consejero | 9 de septiembre de 2026 S | 624 765 | 0 | 8 | $-316 777 |
| Margaret M Fitzpatrick | Consejero | 1 de septiembre de 2026 P | 10 708 | 1 | 0 | $11 602 |
| Stephanie Wong | Consejero | 19 de marzo de 2026 D | · | 0 | 0 | $0 |
| Melvin K Spigelman | Consejero | 19 de marzo de 2026 D | · | 0 | 0 | $0 |
| Joseph S Zakrzewski | · | 14 de agosto de 2026 G | 0 | 0 | 0 | $0 |
| Gilbert Lynn Marks | · | 10 de julio de 2026 A | 81 873 | 0 | 0 | $0 |
| Patricia A. Martin | · | 10 de julio de 2026 A | 18 863 | 0 | 0 | $0 |
| Kabeer Aziz | · | 10 de julio de 2026 A | 59 106 | 0 | 0 | $0 |
| Joshua M Eizen | · | 8 de julio de 2026 S | 206 554 | 0 | 4 | $-52 928 |
| Leonard Braden Michael | · | 28 de mayo de 2025 S | 3 017 432 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 12 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 88 265 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 20 384 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 592 077 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,00% | 29 625 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 35 294 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 360 114 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 853 017 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 153 011 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 321 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 878 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 3 416 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 194 285 SH | 11 de septiembre de 2026 | Diario |
ANTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
COMPRA
Objetivo mediano
$9.00
+57,6%
4 50,0%
Compra fuerte
3 37,5%
Compra
1 12,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-10-03Objetivo medio $9.00 +57,6%
Mín$9.00
Media$9.00
Máx$9.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ANTX | $31M | -1.0 | · | · | -57.7% | · |
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | · |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | · |
| DERM | · | -16.4 | 10.2% | -18.5% | -44.7% | · |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026